Details for New Drug Application (NDA): 011856

NDA 011856 describes SOLU-MEDROL, which is a drug marketed by Pharmacia And Upjohn and is included in one NDA. It is available from seven suppliers. Additional details are available on the SOLU-MEDROL profile page.

The generic ingredient in SOLU-MEDROL is methylprednisolone sodium succinate. There are forty drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the methylprednisolone sodium succinate profile page.

Summary for 011856

Tradename:	SOLU-MEDROL
Applicant:	Pharmacia And Upjohn
Ingredient:	methylprednisolone sodium succinate
Patents:	0

Pharmacology for NDA: 011856

Mechanism of Action

Corticosteroid Hormone Receptor Agonists

Suppliers and Packaging for NDA: 011856

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
SOLU-MEDROL	methylprednisolone sodium succinate	INJECTABLE;INJECTION	011856	NDA	Pharmacia & Upjohn Company LLC	0009-0003	0009-0003-02	1 VIAL in 1 CARTON (0009-0003-02) / 4 mL in 1 VIAL
SOLU-MEDROL	methylprednisolone sodium succinate	INJECTABLE;INJECTION	011856	NDA	Pharmacia & Upjohn Company LLC	0009-0018	0009-0018-20	1 VIAL in 1 CARTON (0009-0018-20) / 8 mL in 1 VIAL

Profile for product number 003

Active Rx/OTC/Discontinued:	RX	Dosage:	INJECTABLE;INJECTION			Strength	EQ 40MG BASE/VIAL
Approval Date:	Approved Prior to Jan 1, 1982	TE:	AP	RLD:	Yes

Profile for product number 004

Active Rx/OTC/Discontinued:	RX	Dosage:	INJECTABLE;INJECTION			Strength	EQ 125MG BASE/VIAL
Approval Date:	Approved Prior to Jan 1, 1982	TE:	AP	RLD:	Yes

Profile for product number 005

Active Rx/OTC/Discontinued:	RX	Dosage:	INJECTABLE;INJECTION			Strength	EQ 500MG BASE/VIAL
Approval Date:	Approved Prior to Jan 1, 1982	TE:	AP	RLD:	Yes

Complete Access Available with Subscription